Literature DB >> 26069251

A Systematic Approach to Defining the microRNA Landscape in Metastasis.

Giridhar Mudduluru1, Mohammed Abba2, Jasmin Batliner1, Nitin Patil2, Maike Scharp1, Taral R Lunavat1, Jörg Hendrik Leupold2, Olga Oleksiuk1, Dilafruz Juraeva3, Wilko Thiele4, Melanie Rothley4, Axel Benner5, Yinon Ben-Neriah6, Jonathan Sleeman4, Heike Allgayer7.   

Abstract

The microRNA (miRNA) landscape changes during the progression of cancer. We defined a metastasis-associated miRNA landscape using a systematic approach. We profiled and validated miRNA and mRNA expression in a unique series of human colorectal metastasis tissues together with their matched primary tumors and corresponding normal tissues. We identified an exclusive miRNA signature that is differentially expressed in metastases. Three of these miRNAs were identified as key drivers of an EMT-regulating network acting though a number of novel targets. These targets include SIAH1, SETD2, ZEB2, and especially FOXN3, which we demonstrated for the first time as a direct transcriptional suppressor of N-cadherin. The modulation of N-cadherin expression had significant impact on migration, invasion, and metastasis in two different in vivo models. The significant deregulation of the miRNAs defining the network was confirmed in an independent patient set as well as in a database of diverse malignancies derived from more than 6,000 patients. Our data define a novel metastasis-orchestrating network based on systematic hypothesis generation from metastasis tissues. ©2015 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26069251     DOI: 10.1158/0008-5472.CAN-15-0997

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  29 in total

1.  Novel tumor-suppressor FOXN3 is downregulated in adult acute myeloid leukemia.

Authors:  Hang He; Jinjing Zhang; Yi Qu; Yue Wang; Yan Zhang; Xiaojing Yan; Yan Li; Rui Zhang
Journal:  Oncol Lett       Date:  2019-05-31       Impact factor: 2.967

2.  MicroRNAs-from metastasis prediction to metastasis prevention?

Authors:  Mohammed Abba; Nitin Patil; Jörg Hendrik Leupold; Heike Allgayer
Journal:  Mol Cell Oncol       Date:  2015-12-10

Review 3.  microRNAs and Corresponding Targets Involved in Metastasis of Colorectal Cancer in Preclinical In Vivo Models.

Authors:  Ulrich H Weidle; Ulrich Brinkmann; Simon Auslaender
Journal:  Cancer Genomics Proteomics       Date:  2020 Sep-Oct       Impact factor: 4.069

4.  A comprehensive framework for analysis of microRNA sequencing data in metastatic colorectal cancer.

Authors:  Eirik Høye; Bastian Fromm; Paul H M Böttger; Diana Domanska; Annette Torgunrud; Christin Lund-Andersen; Torveig Weum Abrahamsen; Åsmund Avdem Fretland; Vegar J Dagenborg; Susanne Lorenz; Bjørn Edwin; Eivind Hovig; Kjersti Flatmark
Journal:  NAR Cancer       Date:  2022-01-14

Review 5.  MicroRNAs Are Key Molecules Involved in the Gene Regulation Network of Colorectal Cancer.

Authors:  Fangfang Yang; Guoyun Xuan; Yixin Chen; Lichao Cao; Min Zhao; Chen Wang; Erfei Chen
Journal:  Front Cell Dev Biol       Date:  2022-04-08

6.  Differentially expressed microRNAs in colorectal cancer metastasis.

Authors:  Mohammed Abba; Axel Benner; Nitin Patil; Oliver Heil; Heike Allgayer
Journal:  Genom Data       Date:  2015-08-05

7.  SNX9 promotes metastasis by enhancing cancer cell invasion via differential regulation of RhoGTPases.

Authors:  Nawal Bendris; Karla C Williams; Carlos R Reis; Erik S Welf; Ping-Hung Chen; Bénédicte Lemmers; Michael Hahne; H S Leong; Sandra L Schmid
Journal:  Mol Biol Cell       Date:  2016-03-09       Impact factor: 4.138

Review 8.  Cancer drug resistance induced by EMT: novel therapeutic strategies.

Authors:  Javier De Las Rivas; Anamaria Brozovic; Sivan Izraely; Alba Casas-Pais; Isaac P Witz; Angélica Figueroa
Journal:  Arch Toxicol       Date:  2021-05-18       Impact factor: 5.153

9.  miRs-134 and -370 function as tumor suppressors in colorectal cancer by independently suppressing EGFR and PI3K signalling.

Authors:  Sherien M El-Daly; Mohammed L Abba; Nitin Patil; Heike Allgayer
Journal:  Sci Rep       Date:  2016-04-20       Impact factor: 4.379

10.  Decreased Expression of SETD2 Predicts Unfavorable Prognosis in Patients With Nonmetastatic Clear-Cell Renal Cell Carcinoma.

Authors:  Weisi Liu; Qiang Fu; Huimin An; Yuan Chang; Weijuan Zhang; Yu Zhu; Le Xu; Jiejie Xu
Journal:  Medicine (Baltimore)       Date:  2015-11       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.